Neogen Upgraded by TheStreet to "Buy"
The analysts wrote, "Neogen Corporation has been upgraded by TheStreet Ratings from hold to buy.
Insider Selling: Neogen VP Unloads 41,022 Shares of Stock
Neogen VP Edward Bradley sold 41,022 shares of the stock on the open market in a transaction dated Tuesday, April 1st.
Pet Pancreas Aid - PanaKare Plus Powder
PanaKare plus Powder, manufactured by the Neogen Corporation, is a concentrated form of pancreatic enzymes containing vitamins A, D, and E. PanaKare plus Powder is prescribed to patients with acute and chronic Pancreatitis.
Insider Selling: Terri A. Morrical Unloads 13,950 Shares of Neogen Stock
Neogen VP Terri A. Morrical sold 13,950 shares of the stock in a transaction that occurred on Wednesday, March 26th.
Neogen Priced Like The Excellent Company It Is
Food safety remains a work in progress in the absence of FDA guidelines, but growing opportunities in China, India, and Brazil merit watching.
Neogen Corp. PT Raised to $53.00
Roth Capital's target price would suggest a potential upside of 12.57% from the company's current price.
Neogen reports third quarter results
Neogen Corporation announced today that its revenues for the third quarter of FY 2014, which ended Feb. 28, increased 21% to $61,996,000, from the previous year's third quarter revenues of $51,055,000.